Signaling via the ErbB-family of receptors plays an important role in mamma
lian development and oncogenesis. Here we show that the ErbB-3 receptor, bu
t not other members of this receptor family, binds to immobilized heparin a
nd can be dissociated only at a high ionic strength comparable to that requ
ired for fibroblast growth factor receptors. Competition-binding analysis s
uggests that this interaction is specific and requires highly sulfated spec
ies of heparan sulfate. Primary sequence analysis of ErbB-3 identified a ba
sic amino acid cluster (KHNRPRR472)-K-466 localized to the proximal, cystei
ne-rich extracellular ligand binding domain of the receptor, with charge de
nsity and distribution compatible with, but different to, known linear hepa
rin binding motifs. Site-directed mutagenesis, replacing this sequence with
the corresponding residues from ErbB-1, resulted in complete loss of hepar
in binding activity of the chimeric receptor. Finally, antibodies directed
to the putative heparin binding peptide, efficiently bind the native recept
or suggesting a novel target for blocking heparin mediated ErbB-3 interacti
ons. (C) 2001 Academic Press.